Morgan Stanley
Filed with the SEC on · accession 0000895421-26-000310
DLB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.5% by the first close after the filing.
Morgan Stanley filed an amended Schedule 13G reporting beneficial ownership of 5.1% of Dolby Laboratories Class A Common Stock as of September 30, 2026, with its subsidiary Atlanta Capital Management Company, LLC holding 3.5% and having ceased to be a more-than-5% beneficial owner.
Close before
$64.59
Nov 12, 2026
First close after
-1.52%
$63.61
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for DLB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DLB?
Click hereDLB filed a SCHEDULE 13G/A (SEC filing). Morgan Stanley filed an amended Schedule 13G reporting beneficial ownership of 5.1% of Dolby Laboratories Class A Common Stock as of September 30, 2026, with its subsidiary Atlanta Capital Management Company, LLC holding 3.5% and having ceased to be a more-than-5% beneficial owner.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
DLB closed at $64.59 before the filing and $63.61 on Nov 13, 2026 (-1.52%).
Get alerts when DLB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days